Evidence map›Paper›PMID 31976596›Full record

ArticleJournal of clinical laboratory analysis2020

Relevance research between the expression of p16

Wenyan Huo, Shuaiyu Zhai, Yanbo Wang, Xin Qiang, Risu Na, Hua Gui, Ningjin Wu, Yaning Cao, Haihua Bai

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical laboratory analysis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Relevance research between the expression of p16Journal of clinical laboratory analysis · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Wenyan HuoAffiliated Hospital of Inner Mongolia University for the Nationalities, Tongliao, China.ORCID https://orcid.org/0000-0002-5302-9689
Shuaiyu ZhaiAffiliated Hospital of Inner Mongolia University for the Nationalities, Tongliao, China.
Yanbo WangInner Mongolia Engineering Research Center of Personalized Medicine, Tongliao, China.ORCID https://orcid.org/0000-0001-9335-2264
Xin QiangMedical school, Inner Mongolia University for Nationalities, Tongliao, China.
Risu NaAffiliated Hospital of Inner Mongolia University for the Nationalities, Tongliao, China.
Hua GuiAffiliated Hospital of Inner Mongolia University for the Nationalities, Tongliao, China.
Ningjin WuXiangYa school of Medicine, Central South University, Changsha, China.
Yaning CaoSchool of Life Science, Inner Mongolia University, Huhehaote, China.
Haihua BaiAffiliated Hospital of Inner Mongolia University for the Nationalities, Tongliao, China.
Inner Mongolia University for Nationalities · CNCentral South University · CNInner Mongolia University · CN

Funding

Inner Mongolia natural science foundation 2017MS (LH) 0823Inner Mongolia Science and Technology Program 201502103Tongliao science and technology planning project TLKJ2017
6 · The paper itself

Abstract

backgroundGLOBOCAN 2018 latest data show cervical cancer ranks fourth in morbidity and mortality among women. Many genes in cervical lesions differ in sensitivity and specificity. However, the diagnostic molecules for early cervical cancer are not very clear. This paper screens biomarkers for early molecular diagnosis of Mongolian patients with cervical cancer.

methodsImmunohistochemical SP method was used to detect the expression of p16

resultsThe positive expression rates of p16

conclusionThe p16

Indexed as

Cyclin-Dependent Kinase Inhibitor p16FemaleGene Expression Regulation, NeoplasticHuman papillomavirus 16HumansOncogene Proteins, ViralPapillomavirus E7 ProteinsPapillomavirus InfectionsReceptor, Notch1Repressor ProteinsRNATelomeraseUterine Cervical NeoplasmsCDKN2A protein, humanCyclin-Dependent Kinase Inhibitor p16E6 protein, Human papillomavirus type 16NOTCH1 protein, humanoncogene protein E7, Human papillomavirus type 16Oncogene Proteins, ViralPapillomavirus E7 ProteinsReceptor, Notch1Repressor ProteinsRNATelomerasetelomerase RNAcervical cancerHPV16hTERC geneNotch1 genep16INK4a geneSiHa cells

Identifiers

PMID31976596
PMCPMC7246350
OpenAlexW3002926203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.